Online inquiry

IVTScrip™ mRNA-Human ACAD11, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK7605MR)

This product GTTS-WK7605MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the ACAD11 protein. This product can be used in Ciliated cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_032169.5
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 84129
UniProt ID Q709F0
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ACAD11, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK7605MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK12753MR IVTScrip™ mRNA-Human ACSM3, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA ACSM3
GTTS-WK27784MR IVTScrip™ mRNA-Human ARSE, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ARSE
GTTS-WK10324MR IVTScrip™ mRNA-Human Acetylcholinesterase, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA Acetylcholinesterase
GTTS-WK11522MR IVTScrip™ mRNA-Human ACE2, (Cap 1, 5-Methoxy-UTP, 120 nt-poly(A)) mRNA ACE2
GTTS-WK5701MR IVTScrip™ mRNA-Human Intestinal Alkaline Phosphatase, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA Intestinal Alkaline Phosphatase
GTTS-WK19363MR IVTScrip™ mRNA-Human AMY2B, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA AMY2B
GTTS-WK12155MR IVTScrip™ mRNA-Human ACSS2, (Cap 1, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ACSS2
GTTS-WK25524MR IVTScrip™ mRNA-Human APOBEC3H, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA APOBEC3H
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
webinar

EABR Nanoparticles as a Platform Technology for Hybrid mRNA Vaccine Development

November 20th, 2024, 2 PM–3 PM EST

REGISTER NOW